·
“Breast cancer is the most common cancer in women worldwide and early detection is critical. In India, one in two women newly diagnosed with breast cancer succumb to it; a staggering statistic that can be dramatically improved with early intervention. UE LifeSciences’ affordable, high-tech iBreastExam device is uniquely positioned to address this challenge effectively in both urban and rural India.”